Literature DB >> 21904493

Polycystic liver disease.

Gregory T Everson1.   

Abstract

Entities:  

Year:  2008        PMID： 21904493      PMCID： PMC3088294     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  8 in total

1.  Laparoscopic palliation of polycystic liver disease.

Authors:  T N Robinson; G V Stiegmann; G T Everson
Journal:  Surg Endosc       Date:  2004-11-11       Impact factor: 4.584

2.  Model for end-stage liver disease (MELD) exception for polycystic liver disease.

Authors:  Luis Arrazola; Dilip Moonka; Robert G Gish; Gregory T Everson
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

3.  The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.

Authors:  Jonathan M Shillingford; Noel S Murcia; Claire H Larson; Seng Hui Low; Ryan Hedgepeth; Nicole Brown; Chris A Flask; Andrew C Novick; David A Goldfarb; Albrecht Kramer-Zucker; Gerd Walz; Klaus B Piontek; Gregory G Germino; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Vicente E Torres; Peter C Harris; Nicholas F Larusso
Journal:  Gastroenterology       Date:  2006-12-20       Impact factor: 22.682

Review 5.  Management of polycystic liver disease.

Authors:  Gregory T Everson; Matthew R G Taylor
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 6.  Polycystic disease of the liver.

Authors:  Gregory T Everson; Matthew R G Taylor; R Brian Doctor
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

7.  Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease.

Authors:  R Sherstha; C McKinley; P Russ; A Scherzinger; T Bronner; R Showalter; G T Everson
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

8.  Sirolimus reduces polycystic liver volume in ADPKD patients.

Authors:  Qi Qian; Hui Du; Bernard F King; Sumedha Kumar; Patrick G Dean; Fernando G Cosio; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 10.121
  8 in total
  5 in total

Review 1.  Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Authors:  Luiz Fernando Norcia; Erika Mayumi Watanabe; Pedro Tadao Hamamoto Filho; Claudia Nishida Hasimoto; Leonardo Pelafsky; Walmar Kerche de Oliveira; Ligia Yukie Sassaki
Journal:  Hepat Med       Date:  2022-09-29

Review 2.  Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease.

Authors:  Frederic Rahbari-Oskoui; Ankush Mittal; Pardeep Mittal; Arlene Chapman
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

3.  Combined liver and kidney transplant in a patient with budd-Chiari syndrome secondary to autosomal dominant polycystic kidney disease associated with polycystic liver disease: report of a case with a 9-year follow-up.

Authors:  Patricia Ramírez de la Piscina; Ileana Duca; Silvia Estrada; Rosario Calderón; Idoia Ganchegui; Amaia Campos; Katerina Spicakova; Leire Urtasun; Marta Salvador; Elvira Delgado; Raquel Bengoa; Francisco García-Campos
Journal:  Case Rep Gastrointest Med       Date:  2014-06-01

4.  "Starry liver" - Von Meyenburg complex clinical case presentation and differential diagnosis discussion: A case report.

Authors:  Kateryna Priadko; Marco Niosi; Luigi Maria Vitale; Chiara De Sio; Marco Romano; Ilario De Sio
Journal:  World J Hepatol       Date:  2022-07-27

5.  The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials.

Authors:  Carlo Garofalo; Ivana Capuano; Luigi Pennino; Ilaria De Gregorio; Eleonora Riccio; Michele Provenzano; Felice Crocetto; Pasquale Buonanno; Savio Domenico Pandolfo; Michele Andreucci; Antonio Pisani
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.